NCT01521325 2016-09-30A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing CancersMorphotekPhase 1 Completed6 enrolled
NCT00325494 2014-07-17A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerMorphotekPhase 1 Completed24 enrolled